Please note that a publication can be assigned to several endpoints, i.e. the sum of publications from the individual thematic points and subpoints can be greater than the total sum of actual publications.
Authors | Year | Exposed system | Parameters | Magnetic flux density/field strength |
---|---|---|---|---|
Wang XK et al. | 2008 | bacterium, <i>Magnetospirillum magneticum</i>/AMB-1 | static magnetic field, geomagnetic field, shielding/field deprivation | 500 nT |
Martino CF et al. | 2010 | intact cell/cell culture, HCT116 cells (colorectal cancer cells) and HT1080 cells (human fibrosarcoma cell line) | static magnetic field, geomagnetic field, shielding/field deprivation | 500 nT–45 µT |
Tessaro LW et al. | 2015 | bacterium, <i>Staphylococcus epidermidis</i>, <i>Staphylococcus aureus</i>, <i>Serratia marcescens</i> and <i>Escherichia coli</i> | magnetic field, static magnetic field, low frequency | 2.1 µT–500 mT |
Ledda M et al. | 2013 | intact cell/cell culture, NT2 (human pluripotent embryonal carcinoma cells) | magnetic field, static magnetic field, low frequency | 2.5–10 µT |
De Carlo F et al. | 2012 | intact cell/cell culture, C2C12 cells (undifferentiated mouse myoblasts) | magnetic field, static magnetic field, low frequency, co-exposure, therapeutic/medical device | 18 µT |
Blackman CF et al. | 1998 | intact cell/cell culture, PC-12 cells (pheochromocytoma cell line from rat adrenal gland) | magnetic field, low frequency, DC, static magnetic field | 23.8–36.6 µT |
Martino CF | 2011 | intact cell/cell culture, human umbilical venous endothelial cells | static magnetic field, DC | 30–120 µT |
Ross SM | 1990 | intact cell/cell culture, rabbit-ligament fibroblast (RLF) cell line | magnetic field, low frequency, 50/60 Hz, DC, static magnetic field | 42–261 µT |
Martino CF et al. | 2010 | intact cell/cell culture, human vein endothelial cells (HUVEC) | static magnetic field, DC | 60–120 µT |
Surma SV et al. | 2014 | intact cell/cell culture, skeletal muscle satellite cells | static magnetic field | 60–400 µT |
This website uses cookies to provide you the best browsing experience. By continuing to use this website you accept our use of cookies.